466 related articles for article (PubMed ID: 21778257)
1. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
[TBL] [Abstract][Full Text] [Related]
2. Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry.
Lazaro Salvador M; Quezada Loaiza CA; Rodríguez Padial L; Barberá JA; López-Meseguer M; López-Reyes R; Sala-Llinas E; Alcolea S; Blanco I; Escribano-Subías P;
Intern Med J; 2021 Mar; 51(3):355-365. PubMed ID: 31943676
[TBL] [Abstract][Full Text] [Related]
3. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
[TBL] [Abstract][Full Text] [Related]
4. Five-Year outcomes of patients enrolled in the REVEAL Registry.
Farber HW; Miller DP; Poms AD; Badesch DB; Frost AE; Muros-Le Rouzic E; Romero AJ; Benton WW; Elliott CG; McGoon MD; Benza RL
Chest; 2015 Oct; 148(4):1043-54. PubMed ID: 26066077
[TBL] [Abstract][Full Text] [Related]
5. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
[TBL] [Abstract][Full Text] [Related]
6. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Shapiro S; Traiger GL; Turner M; McGoon MD; Wason P; Barst RJ
Chest; 2012 Feb; 141(2):363-373. PubMed ID: 21757572
[TBL] [Abstract][Full Text] [Related]
8. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
Awdish RL; Cajigas HR
Lung; 2013 Dec; 191(6):593-600. PubMed ID: 23979006
[TBL] [Abstract][Full Text] [Related]
9. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
Takahashi Y; Yamamoto K; Sakao S; Takeuchi T; Suda R; Tanabe N; Tatsumi K
BMC Pulm Med; 2021 Mar; 21(1):89. PubMed ID: 33726742
[TBL] [Abstract][Full Text] [Related]
10. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
11. Portopulmonary hypertension: survival and prognostic factors.
Le Pavec J; Souza R; Herve P; Lebrec D; Savale L; Tcherakian C; Jaïs X; Yaïci A; Humbert M; Simonneau G; Sitbon O
Am J Respir Crit Care Med; 2008 Sep; 178(6):637-43. PubMed ID: 18617641
[TBL] [Abstract][Full Text] [Related]
12. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.
Frost AE; Farber HW; Barst RJ; Miller DP; Elliott CG; McGoon MD
Chest; 2013 Jan; 143(1):185-195. PubMed ID: 22661451
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
Savale L; Sattler C; Coilly A; Conti F; Renard S; Francoz C; Bouvaist H; Feray C; Borentain P; Jaïs X; Montani D; Parent F; O'Connell C; Hervé P; Humbert M; Simonneau G; Samuel D; Calmus Y; Duvoux C; Durand F; Duclos-Vallée JC; Sitbon O
Hepatology; 2017 May; 65(5):1683-1692. PubMed ID: 27997987
[TBL] [Abstract][Full Text] [Related]
14. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW
Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696
[TBL] [Abstract][Full Text] [Related]
15. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Frost AE; Badesch DB; Barst RJ; Benza RL; Elliott CG; Farber HW; Krichman A; Liou TG; Raskob GE; Wason P; Feldkircher K; Turner M; McGoon MD
Chest; 2011 Jan; 139(1):128-37. PubMed ID: 20558556
[TBL] [Abstract][Full Text] [Related]
16. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
[TBL] [Abstract][Full Text] [Related]
17. Portopulmonary hypertension.
Krowka MJ
Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
[TBL] [Abstract][Full Text] [Related]
19. Survival in schistosomiasis-associated pulmonary arterial hypertension.
dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
[TBL] [Abstract][Full Text] [Related]
20. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
DuBrock HM
Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]